EUR 22.3
(1.83%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 82.37 Million EUR | 4.7% |
2022 | 78.67 Million EUR | 19.84% |
2021 | 65.65 Million EUR | 22.0% |
2020 | 53.81 Million EUR | 41.87% |
2019 | 37.93 Million EUR | 63.65% |
2018 | 23.17 Million EUR | -21.58% |
2017 | 29.55 Million EUR | -5.1% |
2016 | 31.14 Million EUR | -27.14% |
2015 | 42.74 Million EUR | -16.36% |
2014 | 51.1 Million EUR | 11.0% |
2013 | 46.04 Million EUR | 49.29% |
2012 | 30.84 Million EUR | 31.66% |
2011 | 23.42 Million EUR | 28.67% |
2010 | 18.2 Million EUR | 16.68% |
2009 | 15.6 Million EUR | 71.07% |
2008 | 9.12 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 109.1 Million EUR | 0.0% |
2023 Q2 | 114.53 Million EUR | 0.0% |
2023 FY | 82.37 Million EUR | 4.7% |
2023 Q4 | 82.37 Million EUR | 0.0% |
2022 Q4 | 78.67 Million EUR | 0.0% |
2022 Q2 | 100.71 Million EUR | 0.0% |
2022 FY | 78.67 Million EUR | 19.84% |
2021 Q4 | 65.65 Million EUR | 0.0% |
2021 FY | 65.65 Million EUR | 22.0% |
2021 Q2 | 91.93 Million EUR | 0.0% |
2020 Q4 | 53.81 Million EUR | 0.0% |
2020 FY | 53.81 Million EUR | 41.87% |
2020 Q2 | 73.22 Million EUR | 0.0% |
2019 Q4 | 37.93 Million EUR | 0.0% |
2019 Q2 | 64.56 Million EUR | 0.0% |
2019 FY | 37.93 Million EUR | 63.65% |
2018 FY | 23.17 Million EUR | -21.58% |
2018 Q2 | 52.89 Million EUR | 0.0% |
2018 Q4 | 23.17 Million EUR | 0.0% |
2017 Q4 | 29.55 Million EUR | 0.0% |
2017 FY | 29.55 Million EUR | -5.1% |
2017 Q2 | 50.53 Million EUR | 0.0% |
2016 Q2 | 62.94 Million EUR | 0.0% |
2016 Q4 | 31.14 Million EUR | 0.0% |
2016 FY | 31.14 Million EUR | -27.14% |
2015 Q4 | 42.74 Million EUR | 0.0% |
2015 FY | 42.74 Million EUR | -16.36% |
2015 Q2 | 74.89 Million EUR | 0.0% |
2014 Q4 | 51.1 Million EUR | 0.0% |
2014 FY | 51.1 Million EUR | 11.0% |
2014 Q2 | 75.66 Million EUR | 0.0% |
2013 FY | 46.04 Million EUR | 49.29% |
2013 Q4 | 46.04 Million EUR | 0.0% |
2013 Q2 | 70.55 Million EUR | 0.0% |
2012 Q4 | 30.84 Million EUR | 0.0% |
2012 FY | 30.84 Million EUR | 31.66% |
2012 Q2 | 45.79 Million EUR | 0.0% |
2011 Q2 | 41.9 Million EUR | 0.0% |
2011 FY | 23.42 Million EUR | 28.67% |
2011 Q4 | 23.42 Million EUR | 0.0% |
2010 FY | 18.2 Million EUR | 16.68% |
2010 Q4 | 18.2 Million EUR | 0.0% |
2010 Q2 | 36.05 Million EUR | 0.0% |
2009 FY | 15.6 Million EUR | 71.07% |
2009 Q4 | 15.6 Million EUR | 0.0% |
2009 Q2 | 23.29 Million EUR | 0.0% |
2008 FY | 9.12 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
SAS Florentaise | 61.04 Million EUR | -34.94% |
Amoéba S.A. | 10.23 Million EUR | -705.158% |
Biotalys NV | 11.01 Million EUR | -647.962% |